Excessive EZH2 expression was also found to exist in NK/T-cell lymphoma and CLL.398,399 As tumor suppressors, loss-of-function mutations of EZH2 were found in T-ALL, MDS, and MPN.400–402. Here, EZH2 is linked to myeloproliferative disorder.